A new CRISPR-powered blood test can detect faint molecular signs of cancer in a drop of blood before tumors appear on scans, offering new possibilities for earlier diagnosis, scientists in China report.
Women treated with an experimental breast cancer vaccine in the United States have remained alive more than 20 years later, highlighting a breakthrough in long-term immune protection against metastatic cancer.
